Synthesis of a tetranitrosyl iron complex with unique structure and properties as an inhibitor of phosphodiesterases-Reference-Cited by-同舟云学术

Synthesis of a tetranitrosyl iron complex with unique structure and properties as an inhibitor of phosphodiesterases

Published:2023 Issue:47 Volume:52 Page:18090-18101
ISSN:1477-9226
Container-title:Dalton Transactions
language:en
Short-container-title:Dalton Trans.

Author:

Sanina N.A.¹²³^ORCID,Utenyshev A. N.¹,Dorovatovskii P. V.⁴^ORCID,Emel'yanova N. S.¹^ORCID,Ovanesyan N. S.¹^ORCID,Kulikov A. V.¹,Sulimenkov I. V.⁵,Luzhkov V. B.¹^ORCID,Pokidova O. V.¹^ORCID,Aldoshin S. M.¹^ORCID

Affiliation:

1. Federal Research Center of Problems of Chemical Physics and Medicine Chemistry, Russian Academy of Sciences, 1 Acad. Semenov Av., Chernogolovka, 142432, Russia

2. M.V. Lomonosov Moscow State University, 119991, Moscow, Russia

3. Federal State University of Education, 141014, Mytishchi, Russia

4. National Research Center “Kurchatov Institute”, 123182, Moscow, Russia

5. Chernogolovka Branch of N.N. Semenov Federal Research Center for Chemical Physics, Russian Academy of Sciences, Academician Semenov avenue 1/10, Chernogolovka, 142432, Moscow region, Russia

Abstract

A novel neutral tetranitrosyl iron complex {[Fe(H2O)4]2+[FeR2(NO)2]22−}·4H2O (1) with R = 5-(3-pyridyl)-4H-1,2,4-triazole-3-thiolyls (C7H5N4S), which is a supramolecular ensemble, has been synthesized and studied.

Funder

Ministry of Science and Higher Education of the Russian Federation

Publisher

Royal Society of Chemistry (RSC)

Subject

Inorganic Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2023/DT/D3DT03104G

Reference76 articles.

1. Nitric Oxide and Cyclic GMP in Cell Signaling and Drug Development

2. Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments

3. Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors

4. Localized Effects of cAMP Mediated by Distinct Routes of Protein Kinase A

5. The Synthesis of a Selective PDE4/TNFα Inhibitor